• Je něco špatně v tomto záznamu ?

Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis

E. Patrono, J. Svoboda, A. Stuchlík

. 2021 ; 17 (1) : 7. [pub] 20210622

Jazyk angličtina Země Velká Británie

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc22012393

Grantová podpora
CZ.02.2.69/0.0/0.0/19_074/0016409 European Science Foundation
20-00939S Grantová Agentura České Republiky
21-16667K Grantová Agentura České Republiky

Schizophrenia research arose in the twentieth century and is currently rapidly developing, focusing on many parallel research pathways and evaluating various concepts of disease etiology. Today, we have relatively good knowledge about the generation of positive and negative symptoms in patients with schizophrenia. However, the neural basis and pathophysiology of schizophrenia, especially cognitive symptoms, are still poorly understood. Finding new methods to uncover the physiological basis of the mental inabilities related to schizophrenia is an urgent task for modern neuroscience because of the lack of specific therapies for cognitive deficits in the disease. Researchers have begun investigating functional crosstalk between NMDARs and GABAergic neurons associated with schizophrenia at different resolutions. In another direction, the gut microbiota is getting increasing interest from neuroscientists. Recent findings have highlighted the role of a gut-brain axis, with the gut microbiota playing a crucial role in several psychopathologies, including schizophrenia and autism.There have also been investigations into potential therapies aimed at normalizing altered microbiota signaling to the enteric nervous system (ENS) and the central nervous system (CNS). Probiotics diets and fecal microbiota transplantation (FMT) are currently the most common therapies. Interestingly, in rodent models of binge feeding, optogenetic applications have been shown to affect gut colony sensitivity, thus increasing colonic transit. Here, we review recent findings on the gut microbiota-schizophrenia relationship using in vivo optogenetics. Moreover, we evaluate if manipulating actors in either the brain or the gut might improve potential treatment research. Such research and techniques will increase our knowledge of how the gut microbiota can manipulate GABA production, and therefore accompany changes in CNS GABAergic activity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22012393
003      
CZ-PrNML
005      
20220506130744.0
007      
ta
008      
220425s2021 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12993-021-00180-2 $2 doi
035    __
$a (PubMed)34158061
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Patrono, Enrico $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic. enrico.patrono@fgu.cas.cz $1 https://orcid.org/0000000290569537
245    10
$a Schizophrenia, the gut microbiota, and new opportunities from optogenetic manipulations of the gut-brain axis / $c E. Patrono, J. Svoboda, A. Stuchlík
520    9_
$a Schizophrenia research arose in the twentieth century and is currently rapidly developing, focusing on many parallel research pathways and evaluating various concepts of disease etiology. Today, we have relatively good knowledge about the generation of positive and negative symptoms in patients with schizophrenia. However, the neural basis and pathophysiology of schizophrenia, especially cognitive symptoms, are still poorly understood. Finding new methods to uncover the physiological basis of the mental inabilities related to schizophrenia is an urgent task for modern neuroscience because of the lack of specific therapies for cognitive deficits in the disease. Researchers have begun investigating functional crosstalk between NMDARs and GABAergic neurons associated with schizophrenia at different resolutions. In another direction, the gut microbiota is getting increasing interest from neuroscientists. Recent findings have highlighted the role of a gut-brain axis, with the gut microbiota playing a crucial role in several psychopathologies, including schizophrenia and autism.There have also been investigations into potential therapies aimed at normalizing altered microbiota signaling to the enteric nervous system (ENS) and the central nervous system (CNS). Probiotics diets and fecal microbiota transplantation (FMT) are currently the most common therapies. Interestingly, in rodent models of binge feeding, optogenetic applications have been shown to affect gut colony sensitivity, thus increasing colonic transit. Here, we review recent findings on the gut microbiota-schizophrenia relationship using in vivo optogenetics. Moreover, we evaluate if manipulating actors in either the brain or the gut might improve potential treatment research. Such research and techniques will increase our knowledge of how the gut microbiota can manipulate GABA production, and therefore accompany changes in CNS GABAergic activity.
650    _2
$a mozek $7 D001921
650    _2
$a osa mozek-střevo $7 D000087502
650    12
$a střevní mikroflóra $7 D000069196
650    _2
$a lidé $7 D006801
650    _2
$a optogenetika $7 D062308
650    12
$a probiotika $7 D019936
650    12
$a schizofrenie $x terapie $7 D012559
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Svoboda, Jan $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic
700    1_
$a Stuchlík, Aleš $u Institute of Physiology of the Czech Academy of Sciences, Videnska, 1830, Prague, 142 20, Czech Republic. ales.stuchlik@fgu.cas.cz
773    0_
$w MED00163303 $t Behavioral and brain functions : BBF $x 1744-9081 $g Roč. 17, č. 1 (2021), s. 7
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34158061 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220425 $b ABA008
991    __
$a 20220506130736 $b ABA008
999    __
$a ok $b bmc $g 1789826 $s 1163594
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 17 $c 1 $d 7 $e 20210622 $i 1744-9081 $m Behavioral and brain functions $n Behav Brain Funct $x MED00163303
GRA    __
$a CZ.02.2.69/0.0/0.0/19_074/0016409 $p European Science Foundation
GRA    __
$a 20-00939S $p Grantová Agentura České Republiky
GRA    __
$a 21-16667K $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20220425

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...